Dr. Caren F. Behar, MD

Dr. Behar practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Behar's NPI, 1124048780, was assigned on July 19, 2006. Dr. Behar graduated from New York Medical College in 1981. Dr. Behar's New York license number on file is 153722.

Dr. Behar's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Behar's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Behar is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Behar to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Behar practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Behar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Behar is board certified in internal medicine by the American Board of Internal Medicine. Dr. Behar has a license on file in New York.

Dmand AI lists acute sinusitis, acute skin infection, anxiety, arteritis, asthma, chronic diabetes, chronic hypertension and deep vein thrombosis (DVT) among the conditions Dr. Behar treats.

CMS data shows 924 Medicare services from Dr. Behar across 10 procedure codes in 2024, for 313 Medicare patients. Medicare paid $70,664 for them. Every service was in an office.

CMS counts 313 Medicare patients who saw Dr. Behar in 2024. The largest group is 65 to 74, with 157 patients. 70% of them have high cholesterol, and 58% have arthritis. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Behar's median patient age at 66, with 90% women.

In 2024, Dr. Behar wrote 3,003 Medicare Part D claims for 340 patients. 84% of them were for generic drugs. CMS names the drug for 2,427 of them, across 47 drugs with 11 or more claims each, at $276,977 in total drug cost. In 2023, CMS named 2,278 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Behar for performance year 2024, reported as part of a group. Dr. Behar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Behar as offering telehealth.

Dmand AI links 4 papers to Dr. Behar. Dr. Behar has published most often in Heart Dis. Dr. Behar's most frequent co-authors are Stephen J. Peterson, MD, Harold W. Horowitz, MD and Christopher Cummins Nabors, MD.

Dmand AI links Dr. Behar to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Migraine Disorders, Headache and Headache Disorders, Primary. Behar, Caren, M.D. sponsors the most, 2.

CMS Open Payments shows 109 general payments to Dr. Behar from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $392.

Dmand AI lists 2 awards for Dr. Behar, most recently CMS Stage 1 EHR in 2013.

Dr. Behar graduated from New York Medical College in 1981.

Dr. Behar is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.